Krystal Biotech (KRYS) PT Raised to $403 at TD Cowen
Tweet
Share
E-mailGet Alerts KRYS Hot Sheet
Price: $336.80 -0.67%
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 29
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 29
Join SI Premium – FREE
TD Cowen analyst Ritu Baral raised the price target on Krystal Biotech (NASDAQ: KRYS) to $403.00 (from $306.00) while maintaining a Buy rating.
You May Also Be Interested In
- Krystal Biotech to join S&P MidCap 400, Tutor Perini and V2X to join S&P SmallCap 600
- KSB SE & Co KGaA (KSB3:GR) PT Lowered to EUR1,134 at Kepler Cheuvreux
- ACS Actividades de Construccion y Servicios SA (ACS:SM) (ACSAY) PT Lowered to EUR129 at Kepler Cheuvreux
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
